Gilad Shabtai, 10% Owner at Eloxx Pharmaceuticals, Inc. (ELOX), bought 4,500 shares at $9.64 ($43K) on 2018-03-29, disclosed to the SEC on 2018-04-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |